Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions
Event:
ESC Congress 2021 - The Digital Experience
Topic:
Valvular Heart Disease
Session type:
Tutorials
Sponsored by Bristol Myers Squibb and Pfizer
Date:
28 August 2021
Time:
13:15
-
14:15
Congress Session
This content is currently on OPEN ACCESS
1 presentations in this session
2 speakers from this session
Professor Adrian Paul
Banning
John Radcliffe Hospital, Oxford (United Kingdom of Great Britain & Northern Ireland)
7
presentations
0
follower
Doctor Birgid
Gonska
University of Ulm, Ulm (Germany)
2
presentations
0
follower
Related content
ESC Premium Access
Myocarditis associated with COVID vaccines
4 December 2021
This platform is supported by
